Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate)
## Overview
Megacv Duo is a combination antibiotic consisting of amoxicillin (a penicillin-class beta-lactam) and potassium clavulanate (a beta-lactamase inhibitor). The addition of clavulanate extends the spectrum of activity to include beta-lactamase-producing bacteria that are resistant to amoxicillin alone.
## Primary Indications
* Acute bacterial rhinosinusitis
* Community-acquired pneumonia
* Lower respiratory tract infections
* Otitis media
* Skin and skin structure infections
* Urinary tract infections
## Adult Dosing
Standard dosing is based on the amoxicillin component:
* **Mild-to-moderate infections:** 500 mg amoxicillin/125 mg clavulanate every 8 to 12 hours.
* **Severe infections:** 875 mg amoxicillin/125 mg clavulanate every 12 hours.
* **Extended-release formulation:** 2000 mg amoxicillin/125 mg clavulanate every 12 hours (indicated for resistant *S. pneumoniae*).
## Pediatric Dosing
Dosing is strictly weight-based, typically calculated by the amoxicillin component. The standard ratio for pediatric suspensions is 4:1 or 7:1.
* **Standard dose:** 20–45 mg/kg/day (amoxicillin) divided every 8–12 hours.
* **Otitis media/severe infections:** 80–90 mg/kg/day (amoxicillin) divided every 12 hours using the 7:1 (600 mg/5 mL) formulation to minimize clavulanate intake and diarrhea.
## Dose Adjustments
* **Renal Impairment:** Reduce frequency or avoid formulations containing 875 mg or 2000 mg amoxicillin if CrCl < 30 mL/min.
* **Hepatic Impairment:** Use with caution; monitor liver function tests regularly.
## Contraindications
* Known hypersensitivity to amoxicillin, clavulanate, or any penicillin.
* History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate therapy.
* Severe renal impairment (CrCl < 30 mL/min) for formulations containing 875 mg or 2000 mg amoxicillin.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (frequent), nausea, vomiting, *Clostridioides difficile*-associated diarrhea.
* **Hepatic:** Elevated transaminases, cholestatic jaundice (rare, more common in older males).
* **Dermatologic:** Rash (maculopapular rash common in patients with mononucleosis).
* **Hypersensitivity:** Anaphylaxis, SJS/TEN.
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may reduce renal clearance of methotrexate, increasing risk of toxicity.
* **Warfarin:** May increase prothrombin time/INR; monitor closely during initiation or discontinuation.
* **Oral Contraceptives:** May reduce efficacy; recommend barrier protection during therapy.
## Monitoring
* Monitor for signs of hypersensitivity (anaphylaxis) during the first dose.
* Monitor renal function in patients with pre-existing impairment.
* Monitor liver function tests if therapy duration exceeds 14 days.
## Clinical Pearls
* **Administration:** Take with food or a meal to improve GI tolerability and absorption.
* **Clavulanate Loading:** Do not exceed 375 mg of clavulanate per day to avoid severe diarrhea.
* **Formulation Warning:** Use the specific concentration/ratio indicated for the condition (e.g., use 600 mg/5 mL for high-dose pediatric otitis to limit clavulanate content).
* **Cross-Reactivity:** Use with extreme caution in patients with a history of severe immediate-type hypersensitivity reactions to cephalosporins or carbapenems.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify exact dosing against local institutional protocols, current patient weight, and clinical guidelines (e.g., Sanford Guide or Lexicomp) before prescribing or administering medication.
